Revolving Door Between Big Pharma and FDA Regulators Breeding Corruption

Mike Papantonio and Truth In Media’s investigative journalist Ben Swann examine the revolving door phenomenon between the FDA and pharmaceutical companies. The government has capped funding for the FDA, meaning capped salaries for regulators working there. Drug companies are capitalizing on this by offering MASSIVE salaries as a means of buying influence among FDA staff responsible for approving new drugs in an all-out bidding war.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


Time limit is exhausted. Please reload the CAPTCHA.